Risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index.

Risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index.

Registration ID: IJNRD_194478

Published ID: IJNRDTH00069

DOI: Click Here to Get

Sini.K .Oommen

Febrile neutropenia ; Multinational Association of Supportive Care in Cancer (MASCC) risk index ; Chemotherapy

A descriptive study was done to assess the risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index in a selected hospital, Pathnamthitta. The objectives of the study were to assess the risk of complications associated with febrile neutropenia among patients undergoing chemotherapy and to find out the association between the risk of complications associated with febrile neutropenia and the selected baseline variables of the patients undergoing chemotherapy. Descriptive research design was used for the present study. Health promotion model by Nola. J. Pender was used as the conceptual framework for the study. The study was done among 30 patients. The samples were selected using non probability purposive sampling technique. Baseline data assessment proforma and MASCC risk index score were used as the tools for data collection. Descriptive and inferential statistics were used for data analysis. The study identified 56.7% of the samples as high risk group and 43.3% as low risk group. Significant association was found between the MASCC risk index score with type of cancer and history of prior stem cells or bone marrow transplantation. The study concluded that majority of the samples were belong to high risk. This shows patients undergoing chemotherapy have a greater risk for developing complications associated with febrile neutropenia and prompt monitoring is required. MASCC risk index is a reliable tool for assessing the risk of complications among chemotherapy patients.

Published Paper   E-Certificate

"Risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index.", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.8, Issue 8, page no.464-525, August-2023, Available :https://ijnrd.org/papers/IJNRDTH00069.pdf

Volume 8 Issue 8, August-2023

Pages : 464-525

Paper Reg. ID: IJNRD_194478

Published Paper Id: IJNRDTH00069

Downloads: 000121181

Research Area: Health Science 

Country: Pathanamthitta, Kerala, India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00069.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00069

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area